At what enterprise value was PHARMACIE LAFAYETTE - GROUPE HYGIE31 acquired in 2022?

During the acquisition of PHARMACIE LAFAYETTE - GROUPE HYGIE31 by LATOUR CAPITAL in 2022, the transaction's Enterprise Value is estimated to be in the range of 500M - 1.5b EUR.

What was the EV/EBITDA of PHARMACIE LAFAYETTE - GROUPE HYGIE31 when it was acquired by LATOUR CAPITAL?

The estimated EV/EBITDA multiple for PHARMACIE LAFAYETTE - GROUPE HYGIE31 is in the range of 10x - 18x.

What was the revenue of PHARMACIE LAFAYETTE - GROUPE HYGIE31 at the time of the deal?

The revenue of PHARMACIE LAFAYETTE - GROUPE HYGIE31 at the time of the deal is estimated to be in the range of 1b - 3b EUR.

What was the EBITDA of PHARMACIE LAFAYETTE - GROUPE HYGIE31 during the acquisition?

PHARMACIE LAFAYETTE - GROUPE HYGIE31's EBITDA is estimated to be in the range of 25M - 50M EUR.

How is the data for the PHARMACIE LAFAYETTE - GROUPE HYGIE31 acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the PHARMACIE LAFAYETTE - GROUPE HYGIE31 deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://capitalfinance.lesechos.fr/deals/lbo/lenseigne-pharmacie-lafayette-sallie-a-latour-capital-et-a-bpifrance-1776468

What is the average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026?

The average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026 is 14.3x.

← DATABASE

Home Database Healthcare & PharmaPHARMACIE LAFAYETTE - GROUPE HYGIE31

07/2022

PHARMACIE LAFAYETTE - GROUPE HYGIE31 acquired by LATOUR CAPITAL

FRANCE Health Providers / Outpatient Care / Pharmacy EV 500M - 1.5b EUR

Context

Latour Capital and Bpifrance acquired a majority stake in Hygie31, the holding company of Pharmacie Lafayette, from Five Arrows (Rothschild & Co). The deal aims to accelerate the group's development in France and Europe through organic growth and an ambitious buy-and-build strategy.

PHARMACIE LAFAYETTE - GROUPE HYGIE31, which reported an EBITDA margin of in 2021, is valued in this transaction at an EV/EBITDA multiple of , representing a level the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

A leading French network of franchised pharmacies and medical equipment stores. Known for its low-price positioning ("La Sante pour tous"), the group provides purchasing power and digital services to its members to optimize their performance and accessibility.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2021

2020

Similar deals in Health Providers

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
09/2022	EURAZEO	IMAPOLE	FRANCE	Radiology
08/2022	FREEMAN SPOGLI	EVERVET PARTNERS	UNITED STATES	Vet Clinics
07/2022	INFRAVIA CAPITAL	UNIVET	FRANCE	Vet Clinics
07/2022	ANDERA PARTNERS	GROUPE RESONANCE IMAGERIE	FRANCE	Radiology
06/2022	TRITON PARTNERS	ESPERI CARE	FINLAND	Nursing Homes
06/2022	EURAZEO	SEVETYS	FRANCE	Vet Clinics
06/2022	ARDIAN	SIMAGO	FRANCE	Radiology
04/2022	GROUPE BRUXELLES LAMBERT	AFFIDEA	NETHERLANDS	Radiology
02/2022	MEINE RADIOLOGIE	ALERIS - RADIOLOGY	SWEDEN	Radiology
02/2022	PARTNERS GROUP	Forefront Dermatology	UNITED STATES	Outpatient Care

REFERENCES

Valuation range: EV 500M - 1.5b EUR

Revenue range: 1b - 3b EUR

EBITDA range: 25M - 50M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of PHARMACIE LAFAYETTE - GROUPE HYGIE31 by LATOUR CAPITAL are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: pharmacie lafayette - groupe hygie31

Acquirer: latour capital